Hit enter to search or ESC to close
ERA4TB
  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
EventNews

SAVE THE DATE: ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives

ERA4TB is launching a series of webinars aimed at exploring key topics in relation to…
Andrea Garcia
Andrea GarciaOctober 17, 2022
Press

ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’

The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World…
Andrea Garcia
Andrea GarciaSeptember 21, 2022
Event

ERA4TB 5th Consortium Meeting: First F2F meeting in Madrid after the pandemic

On June 20th and 21st the fifth Consortium Meeting took place in Madrid. The meeting…
Andrea Garcia
Andrea GarciaJune 22, 2022
Event

5th Consortium Meeting on 20th and 21st of June 2022 – After 2 years, ERA4TB meets again face to face in Madrid

More than 120 representatives of ERA4TB partners are meeting face to face with the occasion…
IT Synapse
IT SynapseJune 17, 2022
News

ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner

ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau)…
IT Synapse
IT SynapseFebruary 1, 2022
News

The ERA4TB Scientific Advisory Board has been set up

Dr Gilla Kaplan, Ph.D. Former Director of the Global Health Program, Tuberculosis, at the Bill…
IT Synapse
IT SynapseFebruary 1, 2022
Event

ERA4TB 4th Consortium Meeting: The Time to Make a Difference

On the 27th and 28th of January 2022, Consortium members gathered virtually for two days…
IT Synapse
IT SynapseJanuary 31, 2022
News

ERA4TB SCHEDULES THE 4TH CONSORTIUM MEETING ON 27TH AND 28TH OF JANUARY 2022

The ERA4TB 4th Consortium Meeting is taking place next 27th -28th January 2022 as a…
Inari Soininen
Inari SoininenDecember 3, 2021
Press

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…
Inari Soininen
Inari SoininenNovember 26, 2021
Event

Project Update – 3th Consortium Meeting

The third ERA4TB Consortium Meeting took place last June 9th and 10th with the participation…
Inari Soininen
Inari SoininenJune 15, 2021
1 2 Next

Recent Posts

  • SAVE THE DATE: ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives
  • ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’
  • ERA4TB 5th Consortium Meeting: First F2F meeting in Madrid after the pandemic
  • 5th Consortium Meeting on 20th and 21st of June 2022 – After 2 years, ERA4TB meets again face to face in Madrid
  • ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner

Categories

  • Event
  • News
  • Press

TWITTER

ERA4TB ProjectFollow

Research consortium developing new treatments for TB European Regimen Accelerator for Tuberculosis Grant Agreement no. 853989 — ERA4TB https://t.co/BXboc1TV3r

ERA4TB Project
Retweet on TwitterERA4TB Project Retweeted
5 Dec

A recent analysis of the effect of COVID on household Mtb transmission in West Bengal: "secondary attack rate of household TB disease transmission was 34% LOWER during the pandemic period".
https://www.sciencedirect.com/science/article/pii/S001957072200018X

Reply on Twitter 1599805625495564298Retweet on Twitter 15998056254955642983Like on Twitter 15998056254955642987Twitter 1599805625495564298
Retweet on TwitterERA4TB Project Retweeted
30 Nov

🎞️We hope you are catching up on the #UnionConf recordings. Do not miss the plenary sessions and special sessions, including topics like 🎯'Preparing for the Next Pandemic' and 'It's Time to Rethink Respiratory Disease Transmission and How to Prevent It'
📌https://tinyurl.com/yph6976m

Reply on Twitter 1597918506980638721Retweet on Twitter 15979185069806387214Like on Twitter 15979185069806387218Twitter 1597918506980638721
2 Dec

Check out the newest addition of the @AMRAccelerator newsletter for lots of useful updates on a number of IMI-funded research projects focused on #antimicrobials, including ERA4TB!

IMI AMR ACCELERATOR@AMRAccelerator

Just on time for your weekend reading: the freshly released #AMRAccelerator newsletter https://lnkd.in/dMdEdnDc

Get up-to-speed with:
- @TRIC_TB Phase 1 completed
- @AMR_Combine partner interview videos
- New @IMI_ERA4TB webinar series
- & Much more!

#AntimicrobialResistance

Reply on Twitter 1598694450829590530Retweet on Twitter 15986944508295905303Like on Twitter 15986944508295905303Twitter 1598694450829590530
2 Dec

If you weren't able to join us last week, for the launch of our webinar series, you can now watch the session on 'challenges to #tuberculosis drug development and access' on Youtube: https://youtu.be/n6NxPFxHOys
The session was hosted by our partner @NICEComms
#webinar #AMR #WAAW2022

Reply on Twitter 1598680227453992961Retweet on Twitter 15986802274539929612Like on Twitter 15986802274539929613Twitter 1598680227453992961
Retweet on TwitterERA4TB Project Retweeted
1 Dec

On #WorldAIDSDay, we remember all who have died from AIDS-related illnesses, and stand in solidarity with people who are affected by HIV.

TB remains the leading cause of death among those living with #HIV.

📢We must continue advocating for a world free of #HIV #AIDS and #TB.

Reply on Twitter 1598364391753269249Retweet on Twitter 159836439175326924911Like on Twitter 159836439175326924915Twitter 1598364391753269249
Load More...
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2022 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.